Guardant Health GH Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $489.42M-22.3% | $629.76M-44.5% | $1.13B+699% | $141.95M-71.2% | ||
| $823.4M+162% | $314.44M+796% | $35.1M-96.0% | $869.58M+97.4% | ||
| $137.85M+25.0% | $110.25M+24.2% | $88.78M-8.7% | $97.26M-0.4% | ||
| $85.88M+20.8% | $71.08M+14.7% | $61.95M+20.1% | $51.6M+68.2% | ||
| $1.47B+38.9% | $1.06B-21.7% | $1.35B+13.1% | $1.19B+7.0% | ||
| $145.92M+6.7% | $136.81M-5.7% | $145.1M-13.6% | $167.92M+34.9% | ||
| $77.26M+2,248% | $3.29M0.0% | $3.29M0.0% | $3.29M0.0% | ||
| $5.09M-24.7% | $6.76M-24.7% | $8.98M-23.4% | $11.73M-17.5% | ||
| $2.01B+35.5% | $1.49B-16.8% | $1.79B+11.0% | $1.61B-27.0% | ||
| $50.75M+43.1% | $35.47M+97.4% | $17.97M+3.2% | $17.4M+53.7% | ||
| $302.73M+34.2% | $225.58M+9.6% | $205.92M+6.6% | $193.22M-0.8% | ||
| $1.5B+31.6% | $1.14B— | —— | —— | ||
| $2.11B+30.0% | $1.63B-0.2% | $1.63B+5.0% | $1.55B-0.6% | ||
| $1K0.0% | $1K0.0% | $1K0.0% | $1K0.0% | ||
| -$2.99B-16.1% | -$2.58B-20.4% | -$2.14B-28.8% | -$1.66B-65.0% | ||
| -$99.31M+28.9% | -$139.65M-188% | $158.68M+164% | $60.18M-90.7% | ||
| $2.01B+35.5% | $1.49B-16.8% | $1.79B+11.0% | $1.61B-27.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Guardant Health's total assets?
- Guardant Health (GH) holds $1.9B in total assets, up 42.5% year over year.
- How much debt does Guardant Health have?
- Guardant Health carries $1.7B in total debt against -$181.1M of shareholders' equity, a debt-to-equity ratio of 3.03.
- How much cash does Guardant Health have?
- Guardant Health holds $1.1B in cash and equivalents.
- Can Guardant Health cover its short-term obligations?
- Its current ratio is 4.68 — current assets exceed current liabilities.
- Where does Guardant Health's balance sheet data come from?
- Every line is extracted from Guardant Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
